Burning Rock Biotech Limited (BNR)
R&D to Revenue
23.17%
Quarterly · Period ending:
BNR R&D to Revenue
Latest reported23.17%period ending
Latest reported23.17%period ending
BNR Quarterly R&D/Revenue (49.53% → 23.17%)
Latest values, visible window
High-resolution chart · PNG
BNR r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 23.1737% | |
| 25.5311% | |
| 27.6024% | |
| 31.5073% | |
| 33.503% | |
| 30.349% | |
| 41.4237% | |
| 38.2062% | |
| 47.9234% | |
| 52.5262% | |
| 60.3865% | |
| 65.6139% | |
| 65.4819% | |
| 66.2501% | |
| 70.8866% | |
| 70.7704% | |
| 70.3973% | |
| 88.1733% | |
| 76.5034% | |
| 55.0085% | |
| 84.9087% | |
| 72.6053% | |
| 63.3288% | |
| 55.965% | |
| 66.5377% | |
| 59.4335% | |
| 58.9095% | |
| 36.9037% | |
| 41.2578% | |
| 30.0838% | |
| 49.5251% |